Metastatic Castration Resistant Prostate Cancer

Showing 26 - 36 of 36

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relation Between Tumor mRNAs, miRNAs and Treatment Response

Completed
  • Metastatic Castration Resistant Prostate Cancer
  • Enzalutamide, 160mg, 40 mg soft capsules, once daily
  • Den Bosch, Netherlands
  • +2 more
Oct 16, 2020

Metastatic Castration Resistant Prostate Cancer Trial (S410914 tablet)

Unknown status
  • Metastatic Castration Resistant Prostate Cancer
  • S410914 tablet
  • (no location specified)
Jul 24, 2020

Metastatic Castration Resistant Prostate Cancer Trial in Switzerland, United Kingdom, United States (MEDI3726 Post-Chemo,

Completed
  • Metastatic Castration Resistant Prostate Cancer
  • MEDI3726 Post-Chemo
  • +2 more
  • New Haven, Connecticut
  • +4 more
Jan 14, 2020

Optimizing Abiraterone Therapy

Completed
  • Metastatic Castration Resistant Prostate Cancer
  • Abiraterone Acetate
  • Den Bosch, Netherlands
  • +2 more
Sep 12, 2019

Length in mCRPC Patients Treated With Enzalutamide in Sweden

Completed
  • Metastatic Castration Resistant Prostate Cancer
  • Malmo, Sweden
    Site SE46001
Aug 15, 2019

Metastatic Castration Resistant Prostate Cancer Trial in China (Abiraterone Acetate, Placebo, Prednisone)

Completed
  • Metastatic Castration Resistant Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Beijing, Beijing, China
  • +15 more
Aug 13, 2019

Enzalutamide in Metastatic Castration Resistant Prostate Cancer

Completed
  • Metastatic Castration Resistant Prostate Cancer
  • Bregenz, Austria
  • +181 more
Apr 29, 2019

Metastatic Castration Resistant Prostate Cancer Trial in United States (Enzalutamide)

Terminated
  • Metastatic Castration Resistant Prostate Cancer
  • Evanston, Illinois
  • +4 more
Apr 18, 2018

Drug Action in Castration Resistant Prostate Cancer

Completed
  • Metastatic Castration Resistant Prostate Cancer
  • Biopsies, blood and urine samples
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
Jul 25, 2016

Metastatic Castration Resistant Prostate Cancer Trial in Stockholm (Cabazitaxel, weekly cabazitaxel)

Completed
  • Metastatic Castration Resistant Prostate Cancer
  • Stockholm, Sweden
    Deapartment of Oncology Karolinska University Hospital
Oct 30, 2015